CBIO Catalyst Biosciences, Inc. gains 31% May 1, 2020
Targacept, Inc., a biopharmaceutical company, engages in the development of neuronal nicotinic receptors (NNR) therapeutics for the treatment of nervous system and gastrointestinal/genitourinary diseases and disorders.http://www.priceseries.com/trade/CBIO-Catalyst-Biosciences-Inc--stock-gains-31-percent-a-Trade-Record-by-priceSeries-2020040620200501.html